An international team developed nearly 700 new cancer models, derived from patient tumors, which they hope will aid in drug development. The cells represent 25 different types of cancer and are available for researchers around the world to use.
Researchers at EPFL have developed an AI model that learns from tumor tissue data from various cancer types and studies. In the long term, the technology is designed to help better predict disease progression and the success of treatment.